• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG M.BLUE PLUS SYS W/SPRUNG RESERVOIR; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO KG M.BLUE PLUS SYS W/SPRUNG RESERVOIR; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FX844T
Medical Device Problem Codes Obstruction of Flow (2423); Physical Resistance/Sticking (4012)
Health Effect - Clinical Code Hydrocephalus (3272)
Date of Event 04/09/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that an m.Blue plus (#fx844t) was implanted during a procedure performed on an unspecified date.According to the complainant, the shunt system caused an underdrainage and had adjustment difficulties.The patient underwent a revision procedure on (b)(6) 2025.No patient complications were reported as a result of the revision procedure.The complained device was returned to the manufacturer for evaluation.
 
Additional Manufacturer Narrative
Visual inspection: during the investigation, scratches on the outer housing of the valves were determined.Permeability test: a permeability test has shown that both valves are permeable.Computer controlled test: to investigate the claim of under-drainage, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valves are tested in both the horizontal as well as the vertical position.The results show that the valves do not operate within the permissible tolerance in their respective relevant position.A slower outflow of m.Blue and an accelerated of the progav 2.0 could be determined.Adjustment test: the valves were tested and both valves are not adjustable in all pressure settings.Braking force and brake function test: the brake functionality test has shown that the brake function operates as expected.However, the braking force cannot be measured due to the non-adjustability of the valve.Internal inspection: after dismantling of the valves, organic deposits were found in both valves.Results: based on our investigation results, we can determine a slowed outflow in the horizontal position and a non-adjustability on the m.Blue.The deposits visible in the valve have led to the functional impairments.Furthermore, we can determine an accelerated outflow and non-adjustability on the progav 2.0.Here too, the deposits visible in the valve are the cause of the functional impairments.Deposits caused by natural substances found in the body, such as protein, blood, or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.Even small amounts of organic deposits can impair the integrity of the valve.The examination of the returned product is complete with the preparation of this report.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
M.BLUE PLUS SYS W/SPRUNG RESERVOIR
Common Device Name
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM  14469
Manufacturer (Section G)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM   14469
Manufacturer Contact
joerg knebel
ulanenweg 2
potsdam, 14469
GM   14469
MDR Report Key21941706
Report Number3004721439-2025-00133
Device Sequence Number8547789
Product Code JXG
UDI-Device Identifier04041906504878
UDI-Public4041906504878
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
K192266
Number of Events Summarized1
Summary Report (Y/N)N
Device Explanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 05/01/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/07/2023
Device Model NumberFX844T
Device Catalogue NumberFX844T
Device Lot Number20040054
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/16/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/16/2025
Initial Report FDA Received Date05/01/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/07/2023
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age5 YR
Patient SexMale
Patient Weight15 KG
-
-